EP1865980A4 - Abuse-resistant amphetamine prodrugs - Google Patents
Abuse-resistant amphetamine prodrugsInfo
- Publication number
- EP1865980A4 EP1865980A4 EP06769808A EP06769808A EP1865980A4 EP 1865980 A4 EP1865980 A4 EP 1865980A4 EP 06769808 A EP06769808 A EP 06769808A EP 06769808 A EP06769808 A EP 06769808A EP 1865980 A4 EP1865980 A4 EP 1865980A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- abuse
- resistant amphetamine
- amphetamine prodrugs
- prodrugs
- resistant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66938505P | 2005-04-08 | 2005-04-08 | |
US66938605P | 2005-04-08 | 2005-04-08 | |
US68117005P | 2005-05-16 | 2005-05-16 | |
US75654806P | 2006-01-06 | 2006-01-06 | |
US75995806P | 2006-01-19 | 2006-01-19 | |
PCT/US2006/013221 WO2006121552A2 (en) | 2005-04-08 | 2006-04-10 | Abuse-resistant amphetamine prodrugs |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1865980A2 EP1865980A2 (en) | 2007-12-19 |
EP1865980A4 true EP1865980A4 (en) | 2009-11-11 |
Family
ID=37397039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06769808A Withdrawn EP1865980A4 (en) | 2005-04-08 | 2006-04-10 | Abuse-resistant amphetamine prodrugs |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1865980A4 (en) |
JP (1) | JP2008535860A (en) |
BR (1) | BRPI0612440A2 (en) |
CA (1) | CA2603873A1 (en) |
MX (1) | MX2007012507A (en) |
WO (1) | WO2006121552A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318813B2 (en) | 2007-09-13 | 2012-11-27 | Lcs Group, Llc | Method of treating binge eating disorder |
WO2010042120A1 (en) | 2008-10-09 | 2010-04-15 | Archimica, Inc. | Process for the synthesis of amphetamine derivatives |
GB201002612D0 (en) * | 2010-02-16 | 2010-03-31 | Jagotec Ag | Improvements in or relating to organic compounds |
WO2014002039A1 (en) * | 2012-06-27 | 2014-01-03 | Shire Ag | Amphetamine prodrugs |
WO2018118902A1 (en) | 2016-12-19 | 2018-06-28 | The Regents Of The University Of California | Dual-enzyme responsive peptides |
WO2018118903A1 (en) | 2016-12-19 | 2018-06-28 | The Regents Of The University Of California | Noncrushable pill formulatiions |
DK3459538T3 (en) | 2017-09-20 | 2020-08-03 | Sandoz Ag | Crystalline salts of a dextroamphetamine prodrug |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
WO2020212948A1 (en) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
PT3845215T (en) | 2019-12-30 | 2022-10-17 | Labomed Pharmaceutical Company S A | Oral solutions comprising lisdexamfetamine salts |
EP4237007A1 (en) | 2020-11-18 | 2023-09-06 | Mind Medicine, Inc. | Mdma prodrugs to assist psychotherapy |
WO2023111325A1 (en) | 2021-12-16 | 2023-06-22 | Labomed Pharmaceutical Company S.A. | Container comprising a lisdexamfetamine containing oral solution |
WO2024023367A1 (en) | 2022-07-29 | 2024-02-01 | Labomed Pharmaceutical Company S.A. | Lisdexamfetamine containing oral solution |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001005407A1 (en) * | 1999-07-14 | 2001-01-25 | Shire Laboratories, Inc. | Rapid immediate release oral dosage form |
WO2005032474A2 (en) * | 2003-09-30 | 2005-04-14 | New River Pharmaceuticals Inc. | Pharmaceutical compositions for prevention of overdose or abuse |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3878187A (en) * | 1972-09-11 | 1975-04-15 | Syva Co | Polypeptide derivatives of amphetamine and analogs for immunoassays |
DE60219005T2 (en) * | 2001-05-25 | 2007-12-13 | Cephalon, Inc. | Modafinil comprehensive solid pharmaceutical formulations |
US7105486B2 (en) * | 2002-02-22 | 2006-09-12 | New River Pharmaceuticals Inc. | Abuse-resistant amphetamine compounds |
-
2006
- 2006-04-10 EP EP06769808A patent/EP1865980A4/en not_active Withdrawn
- 2006-04-10 MX MX2007012507A patent/MX2007012507A/en unknown
- 2006-04-10 CA CA002603873A patent/CA2603873A1/en not_active Abandoned
- 2006-04-10 WO PCT/US2006/013221 patent/WO2006121552A2/en active Search and Examination
- 2006-04-10 JP JP2008505617A patent/JP2008535860A/en active Pending
- 2006-04-10 BR BRPI0612440-2A patent/BRPI0612440A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001005407A1 (en) * | 1999-07-14 | 2001-01-25 | Shire Laboratories, Inc. | Rapid immediate release oral dosage form |
WO2005032474A2 (en) * | 2003-09-30 | 2005-04-14 | New River Pharmaceuticals Inc. | Pharmaceutical compositions for prevention of overdose or abuse |
Also Published As
Publication number | Publication date |
---|---|
EP1865980A2 (en) | 2007-12-19 |
WO2006121552A3 (en) | 2007-07-05 |
BRPI0612440A2 (en) | 2010-11-23 |
JP2008535860A (en) | 2008-09-04 |
MX2007012507A (en) | 2008-03-11 |
WO2006121552A2 (en) | 2006-11-16 |
CA2603873A1 (en) | 2006-11-16 |
WO2006121552A9 (en) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1865980A4 (en) | Abuse-resistant amphetamine prodrugs | |
PL1968612T3 (en) | Dinucleotide prodrugs | |
GB2424581B (en) | Formulations | |
TWI339780B (en) | Stripper | |
IL187919A0 (en) | 4c | |
EP1909584A4 (en) | Prenylflavonoid formulations | |
GB0505569D0 (en) | Formulations | |
EP1907710A4 (en) | Constructions means | |
AP2008004705A0 (en) | Pnem prodrugs | |
ZA200800365B (en) | Substituted tetrahydroqulnolines | |
GB0421294D0 (en) | Bioreductively-activated prodrugs | |
GB0515699D0 (en) | Prodrugs | |
GB2433078B (en) | Structural member | |
GB0513231D0 (en) | Clear view | |
GB0421296D0 (en) | Bioreductively-activated prodrugs | |
TWM298926U (en) | Assembled paintbrush structure | |
GB0414567D0 (en) | Prodrugs | |
GB0421295D0 (en) | Bioreductively-activated prodrugs | |
AU3621P (en) | Scacover Scaevola aemula | |
AU3685P (en) | DOW10 Tristaniopsis laurina | |
AU3401P (en) | Archise Arctotis fastuosa | |
AU3393P (en) | Breakwell xTriticosecale | |
AU3292P (en) | DP303 Dianella prunina | |
PL372159A1 (en) | Permissible overall dimension | |
GR1007111B (en) | Assembled ballot-box |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070921 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SHIRE LLC |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PICCARIELLO, THOMAS Inventor name: MONCRIEF, JAMES SCOTT Inventor name: LAUDERBACK, CHRISTOPHER Inventor name: OBERLENDER, ROB Inventor name: MICKLE, TRAVIS Inventor name: KRISHNAN, SUMA Inventor name: BISHOP, BARNEY |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PICCARIELLO, THOMAS Inventor name: MONCRIEF, JAMES SCOTT Inventor name: OBERLENDER, ROB Inventor name: MICKLE, TRAVIS Inventor name: KRISHNAN, SUMA Inventor name: BISHOP, BARNEY Inventor name: LAUDERBACK, CHRISTOPHER |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1117036 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090915 |
|
17Q | First examination report despatched |
Effective date: 20091229 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PAUL, BERNHARD J Inventor name: VERBICKY, CHRISTOPHER A Inventor name: PICCARIELLO, THOMAS Inventor name: MONCRIEF, JAMES SCOTT Inventor name: LAUDERBACK, CHRISTOPHER Inventor name: OBERLENDER, ROB Inventor name: MICKLE, TRAVIS Inventor name: KRISHNAN, SUMA Inventor name: BISHOP, BARNEY |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20120207 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1117036 Country of ref document: HK |